Recombinant PRO1933 requires specific storage conditions to maintain stability and activity:
Store at -20°C for regular storage or -80°C for extended storage
For working solutions, maintain aliquots at 4°C for up to one week
Avoid repeated freeze-thaw cycles that can lead to protein degradation
The optimal buffer composition is Tris-based buffer with 50% glycerol
Use small working aliquots rather than repeatedly freezing and thawing the main stock
These conditions are critical for maintaining protein integrity during experimental workflows and ensuring reproducible results across studies.
While specific expression system information for PRO1933 is limited in the literature, the following approaches have proven successful for similar uncharacterized human proteins:
| Expression System | Advantages | Limitations | Recommended Use Case |
|---|---|---|---|
| E. coli (bacterial) | High yield, rapid growth, cost-effective | Limited post-translational modifications, potential inclusion bodies | Initial structural studies, antibody production |
| Yeast (P. pastoris) | Eukaryotic processing, moderate cost, scalable | Hyperglycosylation | Balance between authentic processing and yield |
| Insect cells (Baculovirus) | More complex eukaryotic modifications | Higher cost, longer production time | When bacterial expression fails |
| Mammalian cells (HEK293/CHO) | Human-like modifications, proper folding | Highest cost, lower yields | Functional studies requiring authentic modifications |
For PRO1933, a systematic approach beginning with E. coli expression (as mentioned in product specifications from suppliers) with appropriate tags is recommended, advancing to more complex systems if necessary for specific research objectives .
Purification of recombinant PRO1933 requires a carefully designed protocol:
Initial extraction considerations:
Affinity chromatography approach:
Utilize the affinity tag determined during production (commonly His-tag)
For His-tagged PRO1933, use Immobilized Metal Affinity Chromatography (IMAC) with Ni-NTA or Co-NTA resins
Optimize binding, washing, and elution conditions to maximize purity
Secondary purification:
Quality control:
Verify purity via SDS-PAGE (aim for ≥85% purity)
Confirm identity using Western blotting or mass spectrometry
Assess activity/functionality through appropriate assays
Optimization may require iterative adjustments to buffer compositions, pH, salt concentrations, and chromatography conditions specific to PRO1933's physicochemical properties .
Investigating an uncharacterized protein like PRO1933 requires a multi-tiered experimental strategy:
Bioinformatic analysis (preliminary phase):
Sequence analysis to identify conserved domains and motifs
Structural prediction using tools like AlphaFold
Phylogenetic analysis to identify evolutionary relationships
Literature mining for related proteins
Expression and localization studies (first-tier experiments):
Generate expression constructs with fluorescent tags
Determine subcellular localization in relevant cell types
Assess tissue-specific expression patterns
Analyze expression changes under different conditions
Interaction studies (second-tier experiments):
Implement co-immunoprecipitation coupled with mass spectrometry
Use proximity labeling methods (BioID, APEX)
Perform yeast two-hybrid or mammalian two-hybrid screening
Validate key interactions with orthogonal methods
Functional perturbation (third-tier experiments):
Generate knockout/knockdown models
Perform overexpression studies
Analyze resulting phenotypes using appropriate assays
Conduct rescue experiments with wild-type and mutant constructs
Pathway analysis (integrative experiments):
Transcriptome analysis after PRO1933 manipulation
Proteome and phosphoproteome profiling
Metabolic profiling if appropriate
This systematic approach provides complementary lines of evidence to establish PRO1933's function, with each tier building upon previous findings .
Statistical rigor is essential in studies of uncharacterized proteins like PRO1933:
Experimental design principles:
Control selection:
Include both positive and negative controls appropriate for each assay
For interaction studies, use known non-interacting proteins as negative controls
For functional studies, include well-characterized proteins with similar attributes
Statistical analysis approaches:
Data validation:
Validate key findings using orthogonal methods
Perform cross-validation for predictive models
Report effect sizes along with p-values to assess biological significance
Following these principles will strengthen the reliability and reproducibility of findings related to PRO1933 .
Proteomics offers powerful tools for characterizing uncharacterized proteins:
Protein-protein interaction analysis:
Affinity purification-mass spectrometry (AP-MS) using tagged PRO1933
Proximity labeling (BioID, APEX) to identify the proximal proteome
Cross-linking mass spectrometry to map interaction interfaces
Two-dimensional gel electrophoresis can identify differential protein spots when comparing control and PRO1933-expressing samples
Differential proteomics:
Structural proteomics:
Hydrogen-deuterium exchange mass spectrometry to map protein dynamics
Limited proteolysis coupled with mass spectrometry to identify domains
Native mass spectrometry to determine oligomeric states
Post-translational modification analysis:
Phosphoproteomics to identify regulatory mechanisms
Ubiquitylation analysis to assess protein stability regulation
Glycoproteomics if PRO1933 is predicted to be glycosylated
Integration of these approaches with proper experimental design and statistical analysis can provide comprehensive insights into PRO1933 function .
Without prior knowledge of PRO1933's function, a systematic approach to enzymatic activity detection is required:
Prediction-based screening:
Use bioinformatic tools to predict potential enzymatic functions
Screen for activities based on predicted structural similarities to known enzymes
Test multiple buffer conditions, cofactors, and substrates
Activity-based protein profiling:
Use activity-based probes to identify catalytic mechanisms
Apply chemical proteomics approaches for unbiased activity detection
Screen with compound libraries to identify potential substrates or inhibitors
Metabolite profiling:
Compare metabolite profiles between PRO1933-expressing and control cells
Look for accumulation or depletion of specific metabolites
Trace isotope-labeled potential substrates to detect conversion products
Assay development considerations:
Optimize protein concentration, buffer composition, and reaction conditions
Include appropriate positive and negative controls
Design assays with sufficient sensitivity and dynamic range
Validate with orthogonal methods to confirm specific activity
High-throughput screening:
Develop miniaturized assays suitable for screening if initial tests show promise
Screen against libraries of potential substrates
Use computational approaches to predict enzyme-substrate interactions
This systematic approach maximizes the chance of identifying enzymatic activity in an uncharacterized protein like PRO1933 .
Computational structure prediction provides valuable insights for uncharacterized proteins:
AI-based structure prediction:
AlphaFold2 and RoseTTAFold have revolutionized protein structure prediction
Submit PRO1933 sequence to these platforms for high-confidence structural models
Evaluate prediction confidence scores for different regions
Homology modeling:
Identify templates with similar sequence through BLAST or HHpred
Use software like MODELLER or SWISS-MODEL for model building
Validate models using tools like PROCHECK, VERIFY3D, and MolProbity
Ab initio methods:
Use fragment-based methods like Rosetta for regions lacking homology
Apply molecular dynamics simulations to refine models
Implement coarse-grained modeling for preliminary structural insights
Functional site prediction:
Identify potential binding pockets using tools like CASTp or fpocket
Predict functional sites based on evolutionary conservation
Perform in silico docking to identify potential ligands
Validation and refinement:
Assess model quality using multiple validation metrics
Refine models with molecular dynamics simulations
Compare with experimental data when available
These computational approaches provide testable hypotheses about PRO1933 structure that can guide experimental studies .
Experimental structure determination requires careful consideration of PRO1933's properties:
The choice of method should be guided by research objectives and PRO1933's biochemical properties .
Transcriptomic analysis after PRO1933 manipulation requires rigorous analytical approaches:
Experimental design considerations:
Include appropriate biological replicates (minimum n=3)
Control for confounding variables using strategies like propensity score matching
Design the experiment based on clear hypotheses about PRO1933 function
RNA-seq data analysis workflow:
Quality control and preprocessing of raw sequencing data
Alignment to reference genome or transcriptome assembly
Quantification of gene expression levels
Differential expression analysis with tools like DESeq2 or edgeR
Multiple testing correction to control false discovery rate
Functional interpretation:
Gene Ontology (GO) enrichment analysis
Pathway analysis using resources like KEGG or Reactome
Gene set enrichment analysis (GSEA)
Network analysis to identify co-regulated genes
Integration with other data types:
Correlation with proteomics data if available
Integration with ChIP-seq or other epigenomic data
Comparison with public datasets for context
Validation strategies:
Confirm key findings with qRT-PCR
Validate at the protein level for selected targets
Test predictions with functional assays
This approach can reveal the transcriptional networks and pathways affected by PRO1933, providing insights into its biological role .
Analysis of proteomics data involving PRO1933 requires specialized statistical approaches:
Preprocessing and quality control:
Normalization to account for technical variation
Log transformation to stabilize variance
Assessment of missing values and appropriate imputation strategies
Batch effect correction if necessary
Differential abundance analysis:
Multiple testing correction:
Apply appropriate methods (e.g., Benjamini-Hochberg procedure)
Consider the false discovery rate (FDR) threshold based on study objectives
Report both unadjusted and adjusted p-values for transparency
Multivariate analysis:
Principal Component Analysis (PCA) for dimensionality reduction
Clustering methods to identify protein groups with similar patterns
Network analysis to identify protein modules
Visualization strategies:
These statistical approaches help extract meaningful information from complex proteomics data while controlling false positives and false negatives .
Poor expression of recombinant PRO1933 can result from several factors:
Codon usage optimization issues:
Human proteins often contain codons rare in expression hosts
Solution: Use codon-optimized gene synthesis or Rosetta strains
For PRO1933, analyze the coding sequence for rare codons using tools like Rare Codon Calculator
Toxicity to host cells:
Some proteins may be toxic to the expression host
Signs: Slow growth, plasmid instability, or cell death after induction
Solution: Use tightly controlled inducible promoters, reduce expression temperature (16-20°C), or try different host strains
Protein folding challenges:
Improper folding can lead to aggregation or degradation
Solution: Co-express with chaperones (GroEL/ES, DnaK), use folding-enhancing tags (MBP, SUMO), or adjust induction conditions
Expression conditions:
Suboptimal induction timing or conditions
Solution: Optimize induction OD (typically 0.6-0.8 for E. coli), inducer concentration, and post-induction time
Test expression at different temperatures (37°C for yield, 16-20°C for solubility)
Vector design:
Incompatible promoter or weak ribosome binding site
Solution: Try different expression vectors with stronger or more compatible promoters
Optimize the sequence around the start codon for efficient translation initiation
Systematic optimization of these parameters is recommended to achieve optimal expression of PRO1933 .
Protein degradation during purification can significantly impact studies:
Buffer optimization:
According to specifications, PRO1933 is stable in Tris-based buffer with 50% glycerol
Test different pH conditions (typically pH 7.0-8.0)
Add stabilizing agents such as reducing agents (DTT, β-mercaptoethanol) if the protein contains cysteines
Consider adding mild detergents (0.01-0.05% Tween-20) to prevent aggregation
Protease inhibition strategies:
Add comprehensive protease inhibitor cocktails during extraction and purification
Include specific inhibitors based on observed degradation patterns
Keep samples cold (4°C) throughout the purification process
Consider using protease-deficient expression strains
Chromatography considerations:
Minimize time spent during purification steps
Collect smaller fractions to avoid extended exposure to potentially destabilizing conditions
Consider on-column refolding for proteins expressed as inclusion bodies
Storage optimization:
Follow the recommended storage conditions: -20°C for regular storage or -80°C for extended periods
Prepare small working aliquots to avoid repeated freeze-thaw cycles
Add protein stabilizers like glycerol (final concentration 10-50%) or sucrose
Analytical assessment:
Monitor protein integrity by SDS-PAGE and Western blotting
Use size exclusion chromatography to analyze aggregation state
Consider thermal shift assays to identify stabilizing conditions
Implementing these strategies will help maintain PRO1933 integrity throughout purification and downstream applications .
CRISPR/Cas9 technology provides powerful tools for investigating PRO1933:
Knockout strategies:
Design multiple sgRNAs targeting early exons of PRO1933
Create complete knockout cell lines using CRISPR/Cas9
Confirm knockout by sequencing, RT-PCR, and Western blotting
Perform phenotypic analysis including growth, morphology, and functional assays
Conduct rescue experiments with wild-type PRO1933 to confirm specificity
Endogenous tagging approaches:
Insert epitope tags (HA, FLAG) or fluorescent proteins (GFP, mCherry) at the C- or N-terminus
Use homology-directed repair with appropriate donor templates
This allows visualization and purification of PRO1933 at physiological levels
Essential for studying authentic localization and interactions
Domain mapping:
Create precise deletions of predicted functional domains
Enables mapping of regions required for specific functions or interactions
Design repair templates with specific modifications for homology-directed repair
CRISPR activation/interference:
Use dCas9 fused to transcriptional activators (CRISPRa) or repressors (CRISPRi)
Modulate PRO1933 expression without modifying the genomic sequence
Useful for dose-dependent studies and temporal control
High-throughput CRISPR screens:
Perform genome-wide or focused CRISPR screens with PRO1933 knockout
Identify synthetic lethal or synthetic rescue interactions
Provides insights into functional pathways and potential compensatory mechanisms
These approaches can provide comprehensive insights into PRO1933 function in physiologically relevant contexts .
Integrative multi-omics provides the most comprehensive characterization of uncharacterized proteins:
Combined transcriptomics and proteomics:
Interactome mapping:
Affinity purification-mass spectrometry to identify physical interactors
Proximity labeling to map the spatial environment of PRO1933
Yeast two-hybrid or mammalian two-hybrid screening for binary interactions
Network analysis to place PRO1933 in functional contexts
Structural integration:
Combine computational structure prediction with experimental validation
Map interaction sites and functional domains
Relate structure to identified interactions and functions
Functional genomics integration:
CRISPR screens to identify genetic interactions
Phenotypic profiling after PRO1933 manipulation
Correlation with public functional genomics datasets
Systems biology modeling:
This integrative approach provides multiple lines of evidence to establish PRO1933 function, with each method complementing and validating others while overcoming the limitations of individual techniques .